J. Biol. Chem., Vol. 265, Issue 33, 20247-20251, 11, 1990

Mouse beta thalassemia, a model for the membrane defects of erythrocytes in the human disease

P Rouyer-Fessard, K Leroy-Viard, C Domenget, A Mrad and Y Beuzard
Institut National de la Sante et de la Recherche Medicale U. 91, Hopital Henri Mondor, Creteil, France.

The present study describes the pathophysiology, at the cellular level, of the mouse beta thalassemia and shows the pertinence of this model for the human disease. The homozygous state of mouse beta thalassemia is characterized by a clinical syndrome similar to the human beta thalassemia intermedia, but it cannot be explained by the small deficiency in beta chain synthesis. The small pool of unpaired and soluble alpha chains present in mouse reticulocytes contrasts with the large amount of insoluble alpha chains in erythrocytes which is induced by the high instability of mouse alpha chains and the absence of significant proteolysis. The amount of insoluble alpha chains associated with red cell ghosts is similar in human and mouse disease of similar severity. The study of membrane protein defects showed a decreased amount of spectrin (alpha and beta chains) and dramatic changes in the distribution of the most reactive thiol groups of membrane proteins. These results were similar to that previously described in the human disease (Rouyer-Fessard, P., Garel, M. C., Domenget, C., Guetarni, D., Bachir, D., Colonna, P., and Beuzard, Y. (1989) J. Biol. Chem. 264, 19092-19098). Abnormal density distribution curves of erythrocytes and oxidant-induced lysis of red blood cells used as functional tests were similar in the human and mouse beta thalessemia. We conclude from the present study that 1) mouse beta thalassemia is an excellent model for the membrane defects occurring in the human disease; 2) disease expression is not the reflection of the globin chain unbalance only nor of the soluble pool of alpha hemoglobin chain but mainly is a reflection of insoluble alpha chains; and 3) the rate of proteolysis and instability of alpha chains are important factors which must be taken into consideration in the pathophysiology and the clinical heterogeneity of the disease.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Beauchemin, M.-J. Blouin, and M. Trudel Differential Regulatory and Compensatory Responses in Hematopoiesis/Erythropoiesis in {alpha}- and {beta}-Globin Hemizygous Mice J. Biol. Chem., May 7, 2004; 279(19): 19471 - 19480. [Abstract] [Full Text] [PDF]

				G. F. Atweh, J. DeSimone, Y. Saunthararajah, H. Fathallah, R. S. Weinberg, R. L. Nagel, M. E. Fabry, and R. J. Adams Hemoglobinopathies Hematology, January 1, 2003; 2003(1): 14 - 39. [Abstract] [Full Text] [PDF]

				S. Samakoglu, E. Fattori, S. Lamartina, C. Toniatti, D. Stockholm, J. M. Heard, and D. Bohl {beta}Minor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in {beta} thalassemic mice after erythropoietin complementary DNA electrotransfer in muscles Blood, April 15, 2001; 97(8): 2213 - 2220. [Abstract] [Full Text] [PDF]